The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole
- Conditions
- Gastroesophageal Reflux
- Interventions
- Registration Number
- NCT04720781
- Lead Sponsor
- Showa Inan General Hospital
- Brief Summary
After vonoprazan (20mg/day) or esomeprazole (20mg/day) for 4weeks is prescribed for patients with erosive esophagitis diagnosed by esophagogastroduodenoscopy, the number of patients who will visit our outpatient clinic again due to some reasons without any appointments is compared with vonoprazan group and esomeprazole.
- Detailed Description
1. Patients who have erosive esophagitis diagnosed by esophagogastroduodenoscopy is enrolled.
2. Vonoprazan (20mg/day) or esomeprazole (20mg/day) is prescribed for 4weeks the patients randomly without next appointments.
3. Some patients may visit our outpatient clinic again due to some reasons without any appointments.
4. The number of the patients who revisit our outpatient clinic again is compared with vonoprazan group and esomeprazole.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 300
- outpatients belonging to American Society of Anesthesiologists class I or II
- patients have erosive esophagitis diagnosed by esophagogastroduodenoscopy shortly before the prescription
- other acid blockers are taken
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Vonoprazan Vonoprazan Vonoprazan (20mg/day) is prescribed for patients with erosive esophagitis Esomeprazole Esomeprazole Esomeprazole (20mg/day) is prescribed for patients with erosive esophagitis
- Primary Outcome Measures
Name Time Method The number of patients who revisit our outpatient clinic after the prescription without any appointments 3 months The need to revisit our outpatient clinic again without any appointments may show the patients' satisfaction or dissatisfaction after the prescription of vonoprazan or esomeprazole. The difference in the number between the two groups may show the difference in the effectiveness between the two medicines.
- Secondary Outcome Measures
Name Time Method Change of the main symptom with patients after/before medication when the patients revisit again 3 months The ratio of the degree of the main symptom after/before taking the medicine Good 0%- Bad 100%
Trial Locations
- Locations (1)
Showa Inan General hospital
🇯🇵Komagane, Nagano, Japan